Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.4M Buy
28,964
+4,457
+18% +$228K ﹤0.01% 131
2026
Q2
$1.28M Buy
24,507
+5,684
+30% +$301K ﹤0.01% 132
2026
Q1
$1.04M Buy
18,823
+5,379
+40% +$291K ﹤0.01% 140
2025
Q4
$659K Buy
13,444
+4,727
+54% +$220K ﹤0.01% 142
2025
Q3
$376K Buy
8,717
+1,207
+16% +$47.1K ﹤0.01% 141
2025
Q2
$288K Buy
+7,510
New +$287K ﹤0.01% 142

Other funds holding GSK

Richard Pzena's GSK Position: Q3 2026 in Review

Richard Pzena increased its GSK (GSK) stake by 18% in Q3 2026, buying an estimated $228K and bringing the position to 28,964 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #131.

Richard Pzena first reported a position in GSK in Q2 2025 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Richard Pzena held 28,964 shares of GSK worth $1.4M as of Q3 2026.
  • Richard Pzena bought 4,457 GSK shares in Q3 2026, an estimated $228K.
  • GSK made up ﹤0.01% of Richard Pzena's portfolio in Q3 2026, its #131 holding.
  • Richard Pzena first reported a position in GSK in Q2 2025 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Pzena Investment Management's 13F filing for Q3 2026, filed 30 Oct 2026.